Skip NavigationSkip to Content

Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors

  1. Author:
    Shen, Q.
    Uray, I. P.
    Li, Y. X.
    Zhang, Y.
    Hill, J.
    Xu, X. C.
    Young, M. R.
    Gunther, E. J.
    Hilsenbeck, S. G.
    Colburn, N. H.
    Chodosh, L. A.
    Brown, P. H.
  2. Author Address

    Shen, Qiang, Uray, Ivan P.; Li, Yuxin, Zhang, Yun, Hill, Jamal, Hilsenbeck, Susan G.; Brown, Powel H.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA. [Gunther, Edward J.; Chodosh, Lewis A.] Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA. [Young, Matthew R.; Colburn, Nancy H.] Natl Canc Inst Frederick, Lab Canc Prevent, Frederick, MD USA. [Xu, Xiao-Chun] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA.
    1. Year: 2008
  1. Journal: Cancer Prevention Research
    1. 1
    2. 1
    3. Pages: 45-55
  2. Type of Article: Article
  1. Abstract:

    The oncogene erbB2 is overexpressed in 20% to 30% human breast cancers and is most commonly overexpressed in estrogen receptor (ER)-negative breast cancers. Transgenic mice expressing erbB2 develop ER-negative mammary tumors, mimicking human breast carcinogenesis. Previously, we have shown that activator protein 1 (AP-1) regulates proliferation of

    See More

External Sources

  1. PMID: 19138935

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel